Company profile
Exo Inc
Exo Inc has 4 AI-enabled medical devices on the FDA list. The first decision was on June 22, 2023 and the most recent on April 24, 2025 (Lung AI (LAI001)). Its most common review panel is Radiology (4 devices).
4AI devices
2023First decision
2025Latest decision
1Specialties
Per year
202320242025
By specialty
Related guides
Timeline
- Lung AI (LAI001) · Radiology · MYN
- Strain AI (SAI001) · Radiology · QIH
- AI Platform (AIP001) · Radiology · QIH
- Bladder AI (AIBV01) · Radiology · QIH